CCL2 and metabolic dysfunction-associated steatotic liver disease: In this study, we found that the expression of CCL2 was up-regulated in the livers of NAFLD mice, and that CCL2 could stimulate the migration of SSClowCD11b+Gr1dim MDSCs in vitro (Fig 5).